Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibitors of phosphodiesterase type 5A for treating or preventing muscle disease or the symptoms thereof in a patient

Inhibitors of phosphodiesterase type 5A for treating or preventing muscle disease or the symptoms thereof in a patient

US Patent 9387210 · Granted Jul 12, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of phosphodiesterase type 5A for reducing skeletal muscle fatigue, ed2018
Inhibitors of phosphodiesterase type 5A for reducing skeletal muscle fatigue, ed2018
Inhibitors of phosphodiesterase type 5A for reducing skeletal muscle fatigue, ed2018
Increasing functional glycosylation of alpha-dystroglycan in the treatment of mu2012
Evaluation of adenocarcinoma of the prostate and breast using anti-dystroglycan 2002
Genes encoding neuronal voltage-gated calcium channel gamma subunits2002
Receptor for Mycobacterium leprae and methods of use thereof2001
Gene replacement therapy for muscular dystrophy2001
.delta.-sarcoglycan antibodies2001
Sarcospan-deficient mouse as a model for clinical disorders associated with sarc2001
Pathogenesis of cardiomyopathy2001
Method for aiding in the diagnosis of in-frame deletion type congenital muscular2000